JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2011, Vol. 49 ›› Issue (6): 94-98.

• Articles • Previous Articles     Next Articles

Expressions of HIF-1α and P53 in bronchioloalveolar carcinoma and lung adenocarcinoma with mixed subtypes and their significance

LI Zhen-xiang1, DU Jia-jun1, LIN Xiao-yan2, MU Xue-ru1, WANG Li-guang1, LIU Qi1   

  1. 1. Department of Thoracic Surgery; 2. Department of Pathology, Provincial Hospital Affiliated toShandong University, Jinan 250021, China
  • Received:2010-10-18 Online:2011-06-10 Published:2011-06-10

Abstract:

Objective     To investigate different expressions and correlation of HIF-1α and P53 in bronchioloalveolar carcinoma(BAC) and lung adenocarcinoma with bronchioloalveolar features(ADWBF). Methods     Clinico-pathological factors and paraffin-embedded samples of BAC and ADWBF patients were collected. Clinical data were compared between the two groups.HIF-1α and P53 expressions were detected using the SP immunohistochemical method. Difference and correlation between HIF-1α and P53 expressions in the two groups were analyzed by χ2  test. Results     Statistical analysis showed a significant difference existed in gender and tumor size between BAC and ADWBF(P<0.05). Positive rates of HIF-1α expression in the BAC group and ADWBF group were 25.0%(8/32) and 49.3%(34/69), respectively. Positive rates of P53 expression in the BAC group and ADWBF group were 6.3%(2/32) and 26.1%(18/69), respectively. There was a statistical difference in HIF-1α and P53 expressions between the two groups  (P<0.05).There was a significant positive correlation between HIF-1α and P53 expressions(P<0.05,rp=0.338). Conclusion    HIF-1α and P53 synergistically play important roles in pathogenesis and progression of lung adenocarcinoma.

Key words:  Lung neoplasms; Protein P53; Hypoxia inducible factor-1α

CLC Number: 

  • R734.2
[1] XU Xiao-ya, BI Yu-li, JIANG Man, XU Ji-ying, ZHANG Peng-fei, HAN Ming-yong. Vascular endothelial growth factor (VEGF) promotes lung carcinoma metastasis via VEGFR1 in mouse model [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(11): 25-29.
[2] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(11): 108-110.
[3] TIAN Tian-tian1, LI Ji-sheng1, WANG Ya-wei1, MA Dao-xin2, WANG Xiu-wen1. Genistein exerts antitumor effects in small cell lung cancer H446 cells via suppressing the activity of FoxM1 pathway [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(06): 44-48.
[4] LIU Bing1, YU Zhuang1, HOU Xian-peng1, YAO Ru-yong2. Different expressions of EGFR and HER-3 genes in human lung adenocarcinoma cells and pemetrexed-resistant cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(5): 20-23.
[5] ALIMUJIANG·Stiwaerdi, ZHANG Tao, PATIGULI·Aerxiding, LIU Li. Clinical analysis of recombinant human endostatin combined with gemcitabine and  cisplatin therapy in advanced non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 95-98.
[6] DONG Xue-li, MU Xiao-yan, LIU Qing-liang, SUN Jie. Effects of erlotinib combined with celecoxib on growth and angiogenesis of human lung cancer xenograft model [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(2): 49-52.
[7] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(10): 130-131.
[8] LIU Qing-liang1, MU Xiao-yan1, WANG-Jing2, CHI Xiang-yu2, ZHANG Min3, MA Wei-xia3. Inhibitory effects of RNA interference and Erlotinib by blocking epidermal
growth factor receptor pathway on the proliferation of A549 cells
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 11-.
[9] FAN Heng-jian, ZHANG Yu-ke, XIAO Wei, ZHANG Yi, LI Hai-jun, WANG De-xiang. Changes of Treg and Th17 cells in the peripheral bloods of patients with
lung adenocarcinoma and their prognostic significance
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 73-78.
[10] WANG Ji-xia, LI Gui-xin, HUANG Yan, WANG Li-juan. Expressions and clinical significances of E1AF,MMP-7 and uPA in nonsmall cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(7): 109-.
[11] XU Tong-zhen, SUN Xue-fei, REN Dong-mei, YANG Guo-tao. Antiproliferation activity of luteolin and its role in combined chemotherapy on lung cancer A549 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(7): 50-54.
[12] LIU Hai-rong1, YU Jin-ming2, LI Yan1, LIANG Jing1, LIU Xiao-lin1. Study of the relationship between ER, PR, C-erB-2 and
bone metastasis of  lung adenocacinoma
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(4): 91-.
[13] MA Yu-hua1,2, ZHENG Yan3, JIA Yan-fei3, WANG Yun-shan3. GFR and DEC1 protein co-expression promotes lymph node
metastasis in lung adenocarcinoma
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(3): 24-28.
[14] SUN Xue-fei, PEI Yan-tao,YIN Qiu-wei, YANG Guo-tao, WANG De-jiang. Inhibitory effect of Radix Actinidiae extractive on transplantation
tumor of the lung cancer cell line A549 in nude mice
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 38-42.
[15] LI Peng, LIU Qi, HAN Ming-yong. PET/CT,CEA and CYFRA21-1 predicting the therapeutic effect of targeted drug on non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(1): 129-132.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!